These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9326355)
1. BCL-2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: a comparative study with other chronic B-cell disorders. Lima M; dos Anjos Teixeira M; Queirós ML; Ribeiro dos Santos AH; Justiça B Am J Hematol; 1997 Oct; 56(2):122-5. PubMed ID: 9326355 [TBL] [Abstract][Full Text] [Related]
2. Splenic lymphoma with villous lymphocytes: case report and literature review. Babadoko AA; Hassan A; Ahmed AJ; Isah HA; Suleiman AM Niger J Med; 2007; 16(1):71-3. PubMed ID: 17563973 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268 [TBL] [Abstract][Full Text] [Related]
4. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL. Catovsky D Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958 [TBL] [Abstract][Full Text] [Related]
5. A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation. Shi X; Ba R; You H; Jiang Q; Huang J; Mao J; Han L; Zhang S; Zhuang Q; Yu X; Wang L; Wang Y; Li D; Zhu W; Zhang Y; Zhu Y; Xi X Front Med; 2018 Jun; 12(3):324-329. PubMed ID: 29075958 [TBL] [Abstract][Full Text] [Related]
6. Splenic lymphoma with villous lymphocytes. Gupta R; Naseem S; Sukumaran S; Kashyap R; Kaur S; Paul L Indian J Pathol Microbiol; 2008; 51(1):113-5. PubMed ID: 18417879 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclins D-type in B-chronic lymphoproliferative disorders. Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560 [No Abstract] [Full Text] [Related]
8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686 [TBL] [Abstract][Full Text] [Related]
10. Splenic B-cell lymphoma with villous lymphocytes (SLVL). A lymphocytic lymphoma simulating hairy cell leukemia. A study of 8 cases. Valensi F; Durand V; Bastenaire B; Flandrin G Nouv Rev Fr Hematol (1978); 1990; 32(6):409-14. PubMed ID: 2101874 [TBL] [Abstract][Full Text] [Related]
11. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628 [TBL] [Abstract][Full Text] [Related]
12. [Question of differential diagnosis in a case of chronic B-cell lymphopathy]. Moccia F; Casti P; Morra L Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation. Menendez P; Vargas A; Bueno C; Barrena S; Almeida J; De Santiago M; López A; Roa S; San Miguel JF; Orfao A Leukemia; 2004 Mar; 18(3):491-8. PubMed ID: 14724650 [TBL] [Abstract][Full Text] [Related]
14. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH. Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800 [TBL] [Abstract][Full Text] [Related]
15. The expression of PRAME in chronic lymphoproliferative disorders. Proto-Siqueira R; Falcão RP; de Souza CA; Ismael SJ; Zago MA Leuk Res; 2003 May; 27(5):393-6. PubMed ID: 12620290 [TBL] [Abstract][Full Text] [Related]
16. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of bcl-2 (p26) in CD8(+) lymphocytes of patients with T-cell lymphoproliferative disorders of large granular lymphocytes. Lima M; Teixeira Mdos A; Dos Santos AH; Queirós ML; Justiça B Hematol Oncol; 1997 May; 15(2):81-91. PubMed ID: 9375033 [TBL] [Abstract][Full Text] [Related]
18. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes. Troussard X; Cornet E Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839 [TBL] [Abstract][Full Text] [Related]
19. [Splenic lymphoma with circulating villous lymphocytes]. Colović M; Janković G; Colović R; Mijović A; Antunović P Srp Arh Celok Lek; 1994; 122(3-4):103-4. PubMed ID: 17972822 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]